[HTML][HTML] The regulation of JAKs in cytokine signaling and its breakdown in disease

HM Hammarén, AT Virtanen, J Raivola, O Silvennoinen - Cytokine, 2019 - Elsevier
The JAK–STAT signal transduction pathway is responsible for mediating signals of over fifty
cytokines, growth factors and hormones. Signaling through the JAK–STAT pathway is …

Role of non receptor tyrosine kinases in hematological malignances and its targeting by natural products

KS Siveen, KS Prabhu, IW Achkar, S Kuttikrishnan… - Molecular cancer, 2018 - Springer
Tyrosine kinases belong to a family of enzymes that mediate the movement of the phosphate
group to tyrosine residues of target protein, thus transmitting signals from the cell surface to …

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

Y Liu, J Easton, Y Shao, J Maciaszek, Z Wang… - Nature …, 2017 - nature.com
Genetic alterations that activate NOTCH1 signaling and T cell transcription factors, coupled
with inactivation of the INK4/ARF tumor suppressors, are hallmarks of T-lineage acute …

Pharmacological modulation of the crosstalk between aberrant Janus kinase signaling and epigenetic modifiers of the histone deacetylase family to treat cancer

AHM Mustafa, OH Krämer, L Daws - Pharmacological Reviews, 2023 - Elsevier
Hyperactivated Janus kinase (JAK) signaling is an appreciated drug target in human
cancers. Numerous mutant JAK molecules as well as inherent and acquired drug resistance …

[HTML][HTML] IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update

ML Oliveira, P Akkapeddi, D Ribeiro, A Melão… - Advances in biological …, 2019 - Elsevier
Abstract Interleukin 7 (IL-7) and its receptor (IL-7R, a heterodimer of IL-7Rα and γc) are
essential for normal lymphoid development. In their absence, severe combined …

Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?

E Favoino, M Prete, G Catacchio, P Ruscitti… - Autoimmunity …, 2021 - Elsevier
The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway is
an important intracellular route through which many different extracellular soluble …

Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia

Z Kalender Atak, V Gianfelici, G Hulselmans… - PLoS …, 2013 - journals.plos.org
RNA-seq is a promising technology to re-sequence protein coding genes for the
identification of single nucleotide variants (SNV), while simultaneously obtaining information …

Aberrant signaling pathways in T-cell acute lymphoblastic leukemia

D Bongiovanni, V Saccomani, E Piovan - International journal of …, 2017 - mdpi.com
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the
malignant transformation of immature progenitors primed towards T-cell development …

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

M Kontro, H Kuusanmäki, S Eldfors, T Burmeister… - Leukemia, 2014 - nature.com
STAT5 has an important role in many hematologic malignancies, but constitutive activation
is often a secondary event. 1 Mutations to STAT5B and their functional significance were …

Development of selective covalent Janus kinase 3 inhibitors

L Tan, K Akahane, R McNally… - Journal of medicinal …, 2015 - ACS Publications
The Janus kinases (JAKs) and their downstream effectors, signal transducer and activator of
transcription proteins (STATs), form a critical immune cell signaling circuit, which is of …